However, a subset of FOSCCs with low p53 immunostaining might be associated with TP53 inactivation, since 24%–53% of HNSCC in humans with low p53 immunostaining were related to TP53 mutations [33] (pp. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.